ClinicaliQ Trial Snapshot
- A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma — Recruiting • Respiratory / COPD / Asthma • NCT06286085.
- What is being tested: Concordance between international asthma diagnostic guidelines and evaluation of additional non-guideline physiologic measures (impulse oscillometry/IOS) to detect airways disease beyond standard diagnostic criteria.
- Patient eligibility overview: The trial includes patients suspected of having asthma who require diagnostic assessment, enabling comparison of guideline-recommended testing against supplementary physiologic measurements not currently incorporated into diagnostic protocols.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study aims to assess the concordance of international asthma guidelines in the diagnosis of asthma and explore the presence of airways disease using additional non-guideline physiologic criteria, such as IOS (impulse osciollometry), not included in the guidelines, but available in the Portsmouth lung function service.
Eligibility Snapshot
- : * The patient will meet all the following criteria to be considered eligible for the study: * Aged 18 years or over. * All patients who have attended full asthma workups from November 2021 till date * Willing and able to consent to use their data in this study (opt-out form or e-consent). * Patients referred to the Portsmouth asthma service for diagnosis and further management of presumed asthma. Comorbidities are common in asthma, thus patients with co-existing conditions such as obesity, bronchiectasis or COPD will be included.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.